Gelatin–epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief

References

• TorchilinVPTrubetskoyVSWhich polymers can make nanoparticulate drug carriers long-circulating?Adv Drug Deliv Rev1995162–3141155
   Web of Science ®Google Scholar
• BinstockEEDombAJNanoparticles in ocular drug deliveryDombAJTabataYKumarMNVRFarberSNanoparticles for pharmaceutical applicationsCalifornia, USAAmerican Scientific Publishers2007367376
   Google Scholar
• DaviesNMBiopharmaceutical considerations in topical ocular drug deliveryClin Exp Pharmacol Physiol200027755856210874518
   PubMed Web of Science ®Google Scholar
• DieboldYJarrínMSáezVOcular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)Biomaterials20072881553156417169422
   PubMed Web of Science ®Google Scholar
• KawashimaYYamamotoHTakeuchiHKunoYMucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatoninPharm Dev Technol200051778510669921
   PubMed Web of Science ®Google Scholar
• ChaiyasanWSrinivasSPTiyaboonchaiWMucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surfaceJ Ocul Pharmacol Ther201329220020723356788
   PubMed Web of Science ®Google Scholar
• De CamposAMSánchezAAlonsoMJChitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin AInt J Pharm20012241–215916811472825
   PubMed Web of Science ®Google Scholar
• BourgesJLGautierSEDelieFOcular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticlesInvest Ophthalmol Vis Sci20034483562356912882808
   PubMed Web of Science ®Google Scholar
• de La FuenteMSeijoBAlonsoMJNovel hyaluronic acid-chitosan nanoparticles for ocular gene therapyInvest Ophthalmol Vis Sci20084952016202418436835
   PubMed Web of Science ®Google Scholar
• BaşaranEDemirelMSirmagülBYazanYCyclosporine-A incorporated cationic solid lipid nanoparticles for ocular deliveryJ Microencapsul2010271374719545226
   PubMed Web of Science ®Google Scholar
• GökçeEHSandriGEğrilmezSBonferoniMCGüneriTCaramellaCCyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyesCurr Eye Res20093411996100319958116
   PubMed Web of Science ®Google Scholar
• DjagnyVBWangZXuSGelatin: a valuable protein for food and pharmaceutical industries: reviewCrit Rev Food Sci Nutr200141648149211592686
   PubMed Web of Science ®Google Scholar
• SintzelMBernatchezSFTabatabayCGurnyRBiomaterials in ophthalmic drug deliveryEur J Pharm Biopharm1996426358374
   Web of Science ®Google Scholar
• TsengCLChenKHSuWYLeeYHWuCCLinFHCationic gelatin nanoparticles for drug delivery to the ocular surface: In vitro and in vivo evaluationJ Nanomater20132013111
   Web of Science ®Google Scholar
• McdonaldCCKayeSBFigueiredoFCMacintoshGLockettCA randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndromeEye200216560160712194076
   PubMed Web of Science ®Google Scholar
• HessenMAkpekEKDry eye: an inflammatory ocular diseaseJ Ophthalmic Vis Res20149224025025279127
   PubMedGoogle Scholar
• LempMABaudouinCBaumJDogruMFoulksGNKinoshitaSThe definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShopOcul Surf200752759217508116
   PubMed Web of Science ®Google Scholar
• YoonKCde PaivaCSQiHExpression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stressInvest Ophthalmol Vis Sci20074862561256917525185
   PubMed Web of Science ®Google Scholar
• WilsonSEPerryHDLong-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatmentOphthalmology20071141767917070588
   PubMed Web of Science ®Google Scholar
• LuoLLiDQDoshiAFarleyWCorralesRMPflugfelderSCExperimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surfaceInvest Ophthalmol Vis Sci200445124293430115557435
   PubMed Web of Science ®Google Scholar
• LarrosaMLodoviciMMorbidelliLDolaraPHydrocaffeic and p-coumaric acids, natural phenolic compounds, inhibit UV-B damage in WKD human conjunctival cells in vitro and rabbit eye in vivoFree Radic Res2008421090391018985489
   PubMed Web of Science ®Google Scholar
• CavetMEHarringtonKLVollmerTRWardKWZhangJZAnti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cellsMol Vis20111753354221364905
   PubMed Web of Science ®Google Scholar
• GillespieKKodaniIDickinsonDPEffects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren’s syndrome, an autoimmune diseaseLife Sci20088317–1858158818809413
   PubMed Web of Science ®Google Scholar
• LeeHSChauhanSKOkanoboANallasamyNDanaRTherapeutic efficacy of topical epigallocatechin gallate in murine dry eyeCornea201130121465147221993466
   PubMed Web of Science ®Google Scholar
• FangueiroJFCalpenaACClaresBBiopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studiesInt J Pharm20165021–216116926921515
   PubMed Web of Science ®Google Scholar
• ChangCYWangMCMiyagawaTPreparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularizationInt J Nanomed201712279294
   PubMed Web of Science ®Google Scholar
• ReRPellegriniNProteggenteAPannalaAYangMRice-EvansCAntioxidant activity applying an improved ABTS radical cation decolorization assayFree Radic Biol Med1999269–101231123710381194
   PubMed Web of Science ®Google Scholar
• ShutavaTGBalkundiSSLvovYM(–)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsulesJ Colloid Interface Sci2009330227628319027120
   PubMed Web of Science ®Google Scholar
• TsengCLHungYJChenZYFangHWChenKHSynergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye SyndromePLoS One2016116e015798227336157
   PubMed Web of Science ®Google Scholar
• XiongCChenDLiuJA rabbit dry eye model induced by topical medication of a preservative benzalkonium chlorideInvest Ophthalmol Vis Sci20084951850185618436819
   PubMed Web of Science ®Google Scholar
• TsengCLChenZYRennTYHsiaoSHBurnoufTSolvent/detergent virally inactivated serum eye drops restore healthy ocular epithelium in a rabbit model of dry-eye syndromePLoS One2016114e015357327100624
   PubMed Web of Science ®Google Scholar
• LiNDengXGaoYZhangSHeMZhaoDEstablishment of the mild, moderate and severe dry eye models using three methods in rabbitsBMC Ophthalmol20131315024093832
   PubMedGoogle Scholar
• YehSSongXJFarleyWLiDQSternMEPflugfelderSCApoptosis of ocular surface cells in experimentally induced dry eyeInvest Ophthalmol Vis Sci200344112412912506064
   PubMed Web of Science ®Google Scholar
• AlmediaPFLanesSCSCalargeFAFariasTMBSantanaJCCFTIR characterization of gelatin from chicken feetJ Chem Chem Eng2012610291032
   Google Scholar
• ChenMTanJLianYLiuDPreparation of Gelatin coated hydroxy-apatite nanorods and the stability of its aqueous colloidalAppl Surf Sci2008254927302735
   Web of Science ®Google Scholar
• ChenYCYuSHTsaiGJTangDWMiFLPengYPNovel technology for the preparation of self-assembled catechin/gelatin nanoparticles and their characterizationJ Agric Food Chem201058116728673420476739
   PubMed Web of Science ®Google Scholar
• ZhuBLiJHeYYoshieNInoueYHydrogen-Bonding Interaction and Crystalline Morphology in the Binary Blends of Poly(ɛ-caprolactone) and Polyphenol CatechinMacromol Biosci2003311684693
   Web of Science ®Google Scholar
• GarciaJHsiehMFDomaBPerueloDChenIHLeeHMSynthesis of gelatin-γ-polyglutamic acid-based hydrogel for the In vitro controlled release of epigallocatechin gallate (EGCG) from Camellia sinensisPolymers2014613958
   Web of Science ®Google Scholar
• HondaYTanakaTTokudaTLocal controlled release of poly-phenol conjugated with gelatin facilitates bone formationInt J Mol Sci2015166141431415726110386
   PubMed Web of Science ®Google Scholar
• DengYRenJChenGInjectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for abdominal tissue regenerationSci Rep201771269928578386
   PubMedGoogle Scholar
• LiuHJiaoZGuoSEffect of Epigallocatechin Gallate on the Properties of GelatinInt J Food Prop2014171021192130
   Web of Science ®Google Scholar
• AbelsonMBUdellIJWestonJHNormal human tear pH by direct measurementArch Ophthalmol19819923017469869
   PubMedGoogle Scholar
• BenelliUNardiMPosarelliCAlbertTGTear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectivenessCont Lens Anterior Eye2010332616720153684
   PubMed Web of Science ®Google Scholar
• CraigJPSimmonsPAPatelSTomlinsonARefractive index and osmolality of human tearsOptom Vis Sci199572107187248570161
   PubMed Web of Science ®Google Scholar
• LempMAReport of the National Eye Institute/Industry workshop on Clinical Trials in Dry EyesCLAO J19952142212328565190
   PubMedGoogle Scholar
• LuoLJLaiJYEpigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye SyndromeSci Rep201771938028839279
   PubMedGoogle Scholar
• NagarwalRCKantSSinghPNMaitiPPanditJKPolymeric nanoparticulate system: a potential approach for ocular drug deliveryJ Control Release2009136121319331856
   PubMed Web of Science ®Google Scholar
• ShindeUASheteJNNairHASinghKHEudragit RL100 based microspheres for ocular administration of azelastine hydrochlorideJ Microencapsul201229651151922375685
   PubMed Web of Science ®Google Scholar
• SouzaJGDiasKPereiraTABernardiDSLopezRFTopical delivery of ocular therapeutics: carrier systems and physical methodsJ Pharm Pharmacol201466450753024635555
   PubMed Web of Science ®Google Scholar
• CalvoPAlonsoMJVila-JatoJLRobinsonJRImproved ocular bioavailability of indomethacin by novel ocular drug carriersJ Pharm Pharmacol19964811114711528961163
   PubMed Web of Science ®Google Scholar
• QaddoumiMGUedaHYangJDavdaJLabhasetwarVLeeVHThe characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layersPharm Res200421464164815139521
   PubMed Web of Science ®Google Scholar
• RidoloEMontagniMCaminatiMSennaGIncorvaiaCCanonicaGWEmerging drugs for allergic conjunctivitisExpert Opin Emerg Drugs201419229130224661261
   PubMed Web of Science ®Google Scholar
• KhanNMukhtarHTea polyphenols for health promotionLife Sci200781751953317655876
   PubMed Web of Science ®Google Scholar
• LiZGuLFabrication of self-assembled (−)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cellsJ Agric Food Chem20146261301130924446922
   PubMedGoogle Scholar
• KosarajuSLPuvanenthiranALillfordPNaturally crosslinked gelatin gels with modified material propertiesFood Res Int2010431023852389
   Web of Science ®Google Scholar
• Gómez-MascaraqueLGSolerCLopez-RubioAStability and bioaccessibility of EGCG within edible micro-hydrogels. Chitosan vs. gelatin, a comparative studyFood Hydrocoll201661128138
   Web of Science ®Google Scholar
• PotvinRMakariSRapuanoCJTear film osmolarity and dry eye disease: a review of the literatureClin Ophthalmol201592039204726586933
   PubMed Web of Science ®Google Scholar
• LiuSDozoisMDChangCNProlonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables treatment of eye diseases using significantly reduced dosageMol Pharm20161392897290527482595
   PubMed Web of Science ®Google Scholar
• Di TommasoCValamaneshFMillerFA novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluationInvest Ophthalmol Vis Sci20125342292229922427552
   PubMed Web of Science ®Google Scholar
• ZevinaMOcular anatomy and variations in laboratory animalsWeirABCollinsMAssessing ocular toxicology in laboratory animalsNew YorkHumana Press2013
   Google Scholar
• LeeHShimWKimCEChoiSYLeeHYangJTherapeutic efficacy of nanocomplex of poly(ethylene glycol) and catechin for dry eye disease in a mouse modelInvest Ophthalmol Vis Sci20175831682169128319642
   PubMed Web of Science ®Google Scholar